Alan Fuhrman

This profile gathers the share dealings of Alan Fuhrman across 3 companies, led by Tyra Biosciences, Inc., SpringWorks Therapeutics, Inc. and Esperion Therapeutics, Inc. Over a trading history stretching from 20 May 2021 to 15 September 2026, the count stands at 17 filings.

The open-market record is one-sided, with 1 purchase worth €140k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 share grants.

Most recently, on 17 September 2026, the filings show a share grant worth €7,522 in Tyra Biosciences, Inc. The clock since the last published purchase (1 November 2024) now reads 716 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.